These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 12020548

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Graphical approaches to the analysis of safety data from clinical trials.
    Amit O, Heiberger RM, Lane PW.
    Pharm Stat; 2008; 7(1):20-35. PubMed ID: 17323410
    [Abstract] [Full Text] [Related]

  • 5. [Various pitfalls in cancer clinical trials].
    Sakamoto J, Matsui T, Kodera Y.
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):161-70. PubMed ID: 19223730
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.
    Rauch G, Kieser M, Ulrich S, Doherty P, Rauch B, Schneider S, Riemer T, Senges J.
    Eur J Prev Cardiol; 2014 Jan; 21(1):74-80. PubMed ID: 22964966
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Summarizing the incidence of adverse events using volcano plots and time intervals.
    Zink RC, Wolfinger RD, Mann G.
    Clin Trials; 2013 Jan; 10(3):398-406. PubMed ID: 23690094
    [Abstract] [Full Text] [Related]

  • 11. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems.
    Pocock SJ, Assmann SE, Enos LE, Kasten LE.
    Stat Med; 2002 Oct 15; 21(19):2917-30. PubMed ID: 12325108
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Optimal two-stage designs for clinical trials based on safety and efficacy.
    Thall PF, Cheng SC.
    Stat Med; 2001 Apr 15; 20(7):1023-32. PubMed ID: 11276033
    [Abstract] [Full Text] [Related]

  • 14. Statistical analysis of joint short-term and long-term survival in resuscitation research.
    Babbs CF.
    Resuscitation; 2007 Nov 15; 75(2):323-31. PubMed ID: 17583410
    [Abstract] [Full Text] [Related]

  • 15. Some issues with composite endpoints in clinical trials.
    Chi GY.
    Fundam Clin Pharmacol; 2005 Dec 15; 19(6):609-19. PubMed ID: 16313272
    [Abstract] [Full Text] [Related]

  • 16. Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomes.
    Galbraith S, Marschner IC.
    Stat Med; 2003 Jun 15; 22(11):1787-805. PubMed ID: 12754715
    [Abstract] [Full Text] [Related]

  • 17. Bias in meta-analysis and funnel plot asymmetry.
    Biljana M, Jelena M, Branislav J, Milorad R.
    Stud Health Technol Inform; 1999 Jun 15; 68():323-8. PubMed ID: 10724898
    [Abstract] [Full Text] [Related]

  • 18. Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology.
    Nelson CL, Sun JL, Tsiatis AA, Mark DB.
    Stat Med; 2008 Nov 20; 27(26):5525-55. PubMed ID: 18613251
    [Abstract] [Full Text] [Related]

  • 19. Interpretation of subgroup effects in published trials.
    Hancock MJ, Kjaer P, Korsholm L, Kent P.
    Phys Ther; 2013 Jun 20; 93(6):852-9. PubMed ID: 23431217
    [Abstract] [Full Text] [Related]

  • 20. On the clinical meaningfulness of a treatment's effect on a time-to-event variable.
    Snapinn S, Jiang Q.
    Stat Med; 2011 Aug 30; 30(19):2341-8. PubMed ID: 21520457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.